Publications by authors named "Adedoyin D Abraham"

Claim this Profile
D
Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.
Brett J Prigaro, Hector Esquer, Qiong Zhou, Laura A Pike, Paul Awolade, Adedoyin D Abraham

J Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer.
Hector Esquer, Qiong Zhou, Travis Nemkov, Adedoyin D Abraham, Sébastien Rinaldetti

Oncogene· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced High-Content-Screening Applications of Clonogenicity in Cancer.
Hector Esquer, Qiong Zhou, Adedoyin D Abraham, Daniel V LaBarbera

SLAS Discov· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.
Joshua M Abbott, Qiong Zhou, Hector Esquer, Laura Pike, Travis P Broneske, Adedoyin D Abraham

Mol Cancer Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer.
Adedoyin D Abraham, Hector Esquer, Qiong Zhou, Nicholas Tomlinson, Brayden D Hamill

J Med Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agent.
Linfeng Li, Adedoyin D Abraham, Qiong Zhou, Hadi Ali, Jeremy V O'Brien

Mar Drugs· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.
Linfeng Li, Kun-Che Chang, Yaming Zhou, Biehuoy Shieh, Jessica Ponder, Adedoyin D Abraham

J Med Chem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoamphimedine circumvents metnase-enhanced DNA topoisomerase IIα activity through ATP-competitive inhibition.
Jessica Ponder, Byong Hoon Yoo, Adedoyin D Abraham, Qun Li, Amanda K Ashley

Mar Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis